Global Information
회사소개 | 문의 | 비교리스트

인간 유전자 시퀀싱 시장 : 전략, 동향, 예측(2020-2024년)

Human Gene Sequencing Markets, Strategies & Trends. Forecasts by Hereditary, Newborn Screening, NIPT, Oncology, Pharmacogenomic, and Direct to Consumer, by Country. With Executive and Consultant Guides. 2020 to 2024

리서치사 Howe Sound Research
발행일 2020년 06월 상품 코드 943731
페이지 정보 영문 549 Pages
가격
US $ 6,995 ₩ 8,294,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 10,495 ₩ 12,444,000 PDF by E-mail (Five User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 5대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 13,995 ₩ 16,595,000 PDF by E-mail (Enterprise License) help
동일기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



인간 유전자 시퀀싱 시장 : 전략, 동향, 예측(2020-2024년) Human Gene Sequencing Markets, Strategies & Trends. Forecasts by Hereditary, Newborn Screening, NIPT, Oncology, Pharmacogenomic, and Direct to Consumer, by Country. With Executive and Consultant Guides. 2020 to 2024
발행일 : 2020년 06월 페이지 정보 : 영문 549 Pages

세계의 인간 유전자 시퀀싱(Human Gene Sequencing) 시장에 대해 조사 분석했으며, 시장 개요, 시장 동향, 최근 개발, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론과 시장 정의

제2장 시장 개요

  • 다양한 역할을 완수하는 시장 진출 기업
  • 인간 유전자 시퀀싱 : 시장, 사례, 논의
  • 업계 구조

제3장 시장 동향

  • 성장 촉진요인
  • 성장 저해요인
  • 시퀀싱 계측

제4장 인간 유전자 시퀀싱의 최근 개발

  • 최근 개발
  • 개발의 중요성
  • 사용 방법
    • Yourgene Health
    • NorthShore
    • Germline
    • FDA
    • BillionToOne
    • Mass General, Brigham and Women's Open Clinics
    • Asuragen Fragile
    • Fluxion Bio 등

제5장 주요 기업 개요

  • 10x Genomics, Inc
  • 23andME Inc
  • Abbott Diagnostics
  • AccuraGen Inc.
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Agilent
  • Akonni Biosystems
  • Ancestry.com LLC
  • Anchor Dx
  • ArcherDx, Inc.
  • ARUP Laboratories
  • Asuragen
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • Cancer Genetics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Cepheid(now Danaher
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • Cynvenio
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Exosome Diagnostics
  • Fabric Genomics
  • Fluidigm Corp
  • Foundation Medicine
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • GE Global Research
  • GE Healthcare Life Sciences
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneFirst Ltd
  • Genetron Health(Beijing) Co., Ltd.
  • Genewiz
  • Genomic Health
  • Genomics England
  • Genomics Personalized Health(GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grail, Inc
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helomics
  • Hologic
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Macrogen
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech
  • MIODx
  • miR Scientific
  • MNG Labs
  • Molecular MD
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd
  • Omega Bioservices
  • OncoDNA
  • ORIG3N, Inc.
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen Gmbh
  • Quantumdx
  • Regeneron
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc
  • SkylineDx
  • Stratos Genomics
  • Sure Genomics, Inc.
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc
  • Veritas Genetics
  • Volition

제6장 세계의 인간 게놈 시퀀싱 시장

  • 세계 시장 개요 : 국가별
  • 세계 시장 : 용도별 - 개요

제7장 시장 규모 : 용도별

  • 유전성 유전자 시퀀싱 시장
  • 신생아 유전자 시퀀싱 시장
  • NIPT 유전자 시퀀싱 시장
  • 암 유전자 시퀀싱 시장
  • 약물유전체 유전자 시퀀싱 시장
  • D2C 유전자 시퀀싱 시장

제8장 인간 유전자 시퀀싱의 미래 비전

KSM 20.07.08

Table of Tables

  • Table 1: The Base Pairs
  • Table 2: Most Common Traditional Genetic Disorders
  • Table 3: Lab Spending 2014 to 2024
  • Table 4: List of GLOBAL SEQUENCING LOCATIONS
  • Table 5: Market Players by Type
  • Table 6: The Different Markets for Human Gene Sequencing
  • Table 7: DTC Sub Segments
  • Table 8: The Factors Driving Growth
  • Table 9: Factors Limiting Growth
  • Table 10: - Listing of Current NGS Instrument Specifications
  • Table 11: Six New Sequencing Technologies
  • Table 12: - Global Market by Region
  • Table 13: Global Market by Application
  • Table 14: Hereditary Segment by Country
  • Table 15: Newborn Segment by Country
  • Table 16: NIPT Segment by Country
  • Table 17: Oncology Segment by Country
  • Table 18: Pharmacogenomic Segment by Country
  • Table 19: Direct To Consumer Segment by Country
  • Table 20: 2020 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Clinical Lab Spending 2014 to 2024
  • Figure 2: Gene Sequencing
  • Figure 3: TruSight Germline Panel
  • Figure 4: Historical Cost of Gene Sequencing
  • Figure 5: - Cost To Sequence a Human Genome
  • Figure 6: Base Year Country Market Share Chart
  • Figure 7: Global Market by Application - Base vs. Final Year
  • Figure 8: Global Market by Application Base Year
  • Figure 9: Global Market by Application Final Year
  • Figure 10: Application Type Share by Year
  • Figure 11: by Application Segment Growth
  • Figure 12: Hereditary vs. Total Market Growth
  • Figure 13: Newborn vs. Total Market Growth
  • Figure 14: NIPT vs. Total Market Growth
  • Figure 15: Oncology vs. Total Market Growth
  • Figure 16: Pharmacogenomic vs. Total Market Growth
  • Figure 17: Direct To Consumer vs. Total Market Growth

OVERVIEW:

Will all newborns receive genetic testing at birth? Why has Direct to Consumer Testing taken a big jump? What's holding the industry back? Where are the over 800 locations that have high throughput sequencing devices?

Our facts and support = Your success.

The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Human Gene Sequencing Markets - Strategic Situation Analysis & COVID Impact

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1. Gene Sequencing Definition In This Report
    • 1.1.1. Gene Sequencing
    • 1.1.2. Hereditary
    • 1.1.3. Newborn Screening
    • 1.1.4. Non Invasise Prenatal Testing
    • 1.1.5. Oncology
    • 1.1.6. Pharmacogenomic
    • 1.1.7. Direct to Consumer
  • 1.2. The Genomics Revolution
  • 1.3. Market Definition
    • 1.3.1. Revenue Market Size
  • 1.4. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for laboratory testing
  • 1.5. Genetic Testing vs. Gene Sequencing
    • 1.5.1. Cost and Pricing Practice
  • 1A. Global Listing of Sequencer Installed Base - Location & Contacts
    • 1A.1. Notes to Installed Base Listing

2. Market Overview

  • 2.1. Market Participants Play Different Roles
    • 2.1.1. Instrument Manufacturer
    • 2.1.2. Independent lab specialized/esoteric
    • 2.1.3. Independent lab national/regional
    • 2.1.4. Independent lab analytical
    • 2.1.5. Public National/regional lab
    • 2.1.6. Hospital lab
    • 2.1.7. Physician lab
    • 2.1.8. DTC Lab
    • 2.1.9. Sequencing Labs
    • 2.1.10. Audit body
  • 2.2. Human Gene Sequencing -Markets, Examples and Discussion
    • 2.2.1. Inherited Disease - Not what it used to be
      • 2.2.1.1. Clinical and Research Lines Blur
      • 2.2.1.2. Genetic Counselling - Not so simple anymore
      • 2.2.1.3. The Genetic Blizzard - Issues of Access and Payment
    • 2.2.2. Newborn Screening - The Standard of Care
      • 2.2.2.1. Newborn Screening - Do Parents Want to Know?
    • 2.2.3. NIPT - We've Only Just Begun
      • 2.2.3.1. NIPT, IVF and the Fertility Practice - PGS, PGD, CCS
      • 2.2.3.2. NIPT in the Future - Beyond Inherited Disease
    • 2.2.4. Oncology - Understanding Two Worlds
      • 2.2.4.1. The Tumor - A Sequence of Sequencing
      • 2.2.4.2. The Tumor - Biopsy and Liquid Biopsy
      • 2.2.4.3. The Human Genome - Predisposition and Prognosis
    • 2.2.5. Pharmacogenomics
      • 2.2.5.1. Sequencing Not the Only Player
      • 2.2.5.2. New Roles for Old Drugs - A Research Bonanza?
    • 2.2.6. Direct To Consumer - More Than Meets the Eye
      • 2.2.6.1. DTC - How Many Segments?
  • 2.3. Industry Structure
    • 2.3.1. Hospital's Testing Share
    • 2.3.2. The Rise of the Sequencing Lab
    • 2.3.3. Sequencing as a Commodity
    • 2.3.4. Informatics
    • 2.3.5. Instrument Manufacturer Role
    • 2.3.6. Healthcare Industry Impacts - Still Struggling
    • 2.3.7. Can the Healthcare Industry Adapt?
    • 2.3.8. Genetic Counselling as an Industry
    • 2.3.9. Sequencing Adoption and Cannibalization

3. Market Trends

  • 3.1. Factors Driving Growth
    • 3.1.1. New Diagnoses
    • 3.1.2. Wellness and Prevention
    • 3.1.3. Fertility Technology
    • 3.1.4. Cancer - Screening, Management and Monitoring
  • 3.2. Factors Limiting Growth
    • 3.2.1. Increased Competition Lowers Price
    • 3.2.2. Lower Costs
    • 3.2.3. Healthcare Cost Concerns Curtail Growth.
    • 3.2.4. Wellness has a downside
  • 3.3. Sequencing Instrumentation
    • 3.3.1. Instrumentation Tenacity.
    • 3.3.2. Declining Cost of Instruments Changes Industry Structure.
    • 3.3.3. LISTING of CURRENT INSTRUMENT SPECIFICATIONS
    • 3.3.4. Long Reads - Further Segmentation
    • 3.3.5. Linked Reads
    • 3.3.6. New Sequencing Technologies

4. Human Gene Sequencing Recent Developments

  • 4.1. Recent Developments - Importance and How to Use This Section
    • 4.1.1. Importance of These Developments
    • 4.1.2. How to Use This Section
      • Yourgene Health Gets CE Mark for Iona NIPT Test
      • NorthShore Looks to Expand Genomics Integration Into Primary Care
      • Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients
      • FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
      • BillionToOne Closes $15M Series A Follow-on Round
      • Mass General, Brigham and Women's Open Clinics to Integrate Genomics Into Primary Care
      • Asuragen Fragile X Diagnostic Test Gets FDA Authorization
      • Fluxion Bio Wins NIH Grant to Develop NIPT Assay
      • Illumina, Broad Institute Collaborate on Genome Analysis Software
      • Illumina, Adaptive Biotechnologies Partner on IVD Test Kits for Immune Sequencing
      • Menarini Silicon Biosystems, BlueBee Partner on Sequencing Data Analysis Platform
      • Paying cash for elective genomic sequencing
      • NIH funds Color ahead of million-person sequencing effort
      • Veritas Genetics slashes price of whole genome sequencing 40% to $600
      • Superfast gene sequencing diagnoses critically ill patients
      • Veracyte Details Clinical Utility of RNA Sequencing-Based Testing for Thyroid Cancer
      • Longas Technologies Launches. Offers 'Virtual Long Read' Library Prep
      • New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier
      • PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive
      • Health Management
      • Roche Gets CE Mark for Mutation Profiler Software for NGS Cancer Tests
      • PGDx and PathGroup Enter Co-Development Agreement
      • Newborn genomic sequencing detects unanticipated disease risk factors

5. Profiles of Key Companies

  • 10x Genomics, Inc
  • 23andME Inc
  • Abbott Diagnostics
  • AccuraGen Inc.
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Agilent
  • Akonni Biosystems
  • Ancestry.com LLC
  • Anchor Dx
  • ArcherDx, Inc.
  • ARUP Laboratories
  • Asuragen
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • Cancer Genetics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Cepheid (now Danaher
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • Cynvenio
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Exosome Diagnostics
  • Fabric Genomics
  • Fluidigm Corp
  • Foundation Medicine
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • GE Global Research
  • GE Healthcare Life Sciences
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneFirst Ltd
  • Genetron Health (Beijing) Co., Ltd.
  • Genewiz
  • Genomic Health
  • Genomics England
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grail, Inc
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helomics
  • Hologic
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Macrogen
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech
  • MIODx
  • miR Scientific
  • MNG Labs
  • Molecular MD
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd
  • Omega Bioservices
  • OncoDNA
  • ORIG3N, Inc.
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen Gmbh
  • Quantumdx
  • Regeneron
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc
  • SkylineDx
  • Stratos Genomics
  • Sure Genomics, Inc.
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc
  • Veritas Genetics
  • Volition

6. The Global Market for Human Genome Sequencing

  • 6.1. Global Market Overview by Country
    • 6.1.1. Table - Global Market by Country
    • 6.1.2. Chart - Global Market by Country
  • 6.2. Global Market by Application - Overview
    • 6.2.1. Table - Global Market by Application
    • 6.2.2. Chart - Global Market by Application - Base/Final Year Comparison
    • 6.2.3. Chart - Global Market by Application - Base Year
    • 6.2.4. Chart - Global Market by Application - Final Year
    • 6.2.5. Chart - Global Market by Application - Share by Year
    • 6.2.6. Chart - Global Market by Application - Segment Growth

7. Market Sizes by Application

  • 7.1. Hereditary Gene Sequencing Market
  • 7.2. Newborn Gene Sequencing Market
  • 7.3. NIPT Gene Sequencing Market
  • 7.4. Oncology Gene Sequencing Market
  • 7.5. Pharmacogenomic Gene Sequencing Market
  • 7.6. Direct To Consumer Gene Sequencing Market

8. Vision of the Future of Human Gene Sequencing

Appendices

I. United States Medicare System: January 2020 laboratory Fees Schedule

II. The Whole Genome Sequence of SARS-CoV-2

III. Methodology

  • II.1. Authors
  • II.2. Sources

II. Methodology

  • II.1. Authors
  • II.2. Sources
Back to Top
전화 문의
F A Q